In a cohort of 183 ET patients from the Mayo Clinic, TET2 mutation showed a significant association with ET thrombosis independent of age and driver mutation status, but this association was not evident in either PV or a cohort of 174 ET patients from the University of Florence, Italy [25]. The gene discussed is TET2; the disease is essential thrombocythemia.